Literature DB >> 14984346

6: Thyroid nodules and thyroid cancer.

Emily J Mackenzie1, Robin H Mortimer.   

Abstract

Thyroid nodules are common clinically (prevalence, about 5%) and even more common on ultrasound examination (about 25%). About 5% of thyroid nodules are malignant. Most thyroid cancers are well-differentiated papillary or follicular tumours with an excellent prognosis (10-year survival, 80%-95%). The incidence of papillary thyroid cancer appears to be increasing on the east coast of Australia. Fine-needle aspiration biopsy of the thyroid is the most cost-effective diagnostic tool. Recommended initial management of all follicular carcinomas and of papillary carcinomas > 1.0 cm is total thyroidectomy followed by radioiodine ablation. Most patients should be managed postoperatively with doses of thyroid hormone sufficient to suppress plasma levels of thyroid-stimulating hormone. Recurrences can occur many years after initial therapy, and follow-up should be lifelong. Thyroid nodules are very common, but have a relatively low risk of malignancy

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14984346     DOI: 10.5694/j.1326-5377.2004.tb05894.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  14 in total

1.  Acoustic Radiation Force Impulse (ARFI) imaging for the distinction between benign and malignant thyroid nodules.

Authors:  Cihad Hamidi; Cemil Göya; Salih Hattapoğlu; Ömer Uslukaya; Memik Teke; Mehmet Sedat Durmaz; Mehmet Sıddık Yavuz; Arif Hamidi; Güven Tekbaş
Journal:  Radiol Med       Date:  2015-01-16       Impact factor: 3.469

2.  Acoustic radiation force impulse elastography for differentiation of benign and malignant thyroid nodules with concurrent Hashimoto's thyroiditis.

Authors:  Bo-Ji Liu; Hui-Xiong Xu; Yi-Feng Zhang; Jun-Mei Xu; Dan-Dan Li; Xiao-Wan Bo; Xiao-Long Li; Le-Hang Guo; Xiao-Hong Xu; Shen Qu
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

3.  Poly r(C) binding protein (PCBP) 1 expression is regulated at the post-translation level in thyroid carcinoma.

Authors:  Ming-Peng Zhang; Wei-San Zhang; Jin Tan; Ming-Hui Zhao; Lin-Juan Lian; Jie Cai
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Poly r(C) binding protein (PCBP) 1 is a negative regulator of thyroid carcinoma.

Authors:  Mingpeng Zhang; Xin Wang; Jin Tan; Minghui Zhao; Linjuan Lian; Weisan Zhang
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

5.  TSH alone is not sufficient to exclude all patients with a functioning thyroid nodule from undergoing testing to exclude thyroid cancer.

Authors:  Luis-Mauricio Hurtado-López; Blanca-Estela Monroy-Lozano; Carlos Martínez-Duncker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

6.  Metastatic phenotype is regulated by estrogen in thyroid cells.

Authors:  Shilpi Rajoria; Robert Suriano; Arulkumaran Shanmugam; Yushan Lisa Wilson; Stimson P Schantz; Jan Geliebter; Raj K Tiwari
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

7.  Combined (99m)Tc-methoxyisobutylisonitrile scintigraphy and fine-needle aspiration cytology offers an accurate and potentially cost-effective investigative strategy for the assessment of solitary or dominant thyroid nodules.

Authors:  Anita Wale; Kenneth A Miles; Barnaby Young; Charles Zammit; Anthony Williams; John Quin; Sabina Dizdarevic
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

Review 8.  Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases.

Authors:  Chao Ma; Anren Kuang; Jiawei Xie
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

9.  Alternative splicing events implicated in carcinogenesis and prognosis of thyroid gland cancer.

Authors:  Zeng-Hong Wu; Yun Tang; Yue Zhou
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

10.  [Analysis of predictors of malignancy of nodular goiters: about 500 cases].

Authors:  Brahim Bouaity; Youssef Darouassi; Mehdi Chihani; Mohamed Mliha Touati; Haddou Ammar
Journal:  Pan Afr Med J       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.